Literature DB >> 2116237

The neurofibromatosis type 1 gene encodes a protein related to GAP.

G F Xu1, P O'Connell, D Viskochil, R Cawthon, M Robertson, M Culver, D Dunn, J Stevens, R Gesteland, R White.   

Abstract

cDNA walking and sequencing have extended the open reading frame for the neurofibromatosis type 1 gene (NF1). The new sequence now predicts 2485 amino acids of the NF1 peptide. A 360 residue region of the new peptide shows significant similarity to the known catalytic domains of both human and bovine GAP (GTPase activating protein). A much broader region, centered around this same 360 amino acid sequence, is strikingly similar to the yeast IRA1 product, which has a similar amino acid sequence and functional homology to mammalian GAP. This evidence suggests that NF1 encodes a cytoplasmic GAP-like protein that may be involved in the control of cell growth by interacting with proteins such as the RAS gene product. Mapping of the cDNA clones has confirmed that NF1 spans a t(1;17) translocation mutation and that three active genes lie within an intron of NF1, but in opposite orientation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116237     DOI: 10.1016/0092-8674(90)90024-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  277 in total

1.  A novel NF1 gene mutation in an Italian family with neurofibromatosis type 1.

Authors:  Anna Lia Gabriele; Martino Ruggieri; Alessandra Patitucci; Angela Magariello; Francesca Luisa Conforti; Rosalucia Mazzei; Maria Muglia; Carmine Ungaro; Gemma Di Palma; Luigi Citrigno; William Sproviero; Antonio Gambardella; Aldo Quattrone
Journal:  Childs Nerv Syst       Date:  2010-10-07       Impact factor: 1.475

Review 2.  Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review.

Authors:  Aamira Huq; Maira Kentwell; Amanda Tirimacco; Jacqueline Rossini; Lesley Rawlings; Ingrid Winship
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

Review 3.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 4.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

5.  Attenuation of GTPase activity of recombinant G(o) alpha by peptides representing sequence permutations of mastoparan.

Authors:  C Oppi; T Wagner; A Crisari; B Camerini; G P Tocchini Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 6.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

7.  Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Authors:  Karlyne M Reilly
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

Review 8.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

9.  Neurofibromin is the major ras inactivator in dendritic spines.

Authors:  Ana F Oliveira; Ryohei Yasuda
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.